Presse Med 2014 Nov 24;43(11):1285-7. Epub 2014 Jul 24.
Aix-Marseille université, AP-HM, hôpital de la Conception, service d'anesthésie et de réanimation, 13385 Marseille, France.
Enferm Infecc Microbiol Clin 2021 Dec 15. Epub 2021 Dec 15.
Unidad NRBQ-Infecciosas. Sección de Infecciosas. UAAN. Hospital Central de la Defensa "Gómez Ulla", Madrid, Spain.
Introduction: The generalization of treatment with dexamethasone or other immunosuppressants in patients with SARS-CoV-2 infection may increase the risk of occurrence of severe forms of strongyloidiasis. A nationwide survey was conducted to better understand the diagnostic and therapeutic situation of strongyloidiasis in SARS-CoV-2 co-infected patients in Spain.Materials And Methods: A survey was designed and sent to all SEIMC members during February and March 2021. Read More
Am J Trop Med Hyg 2021 Nov 29. Epub 2021 Nov 29.
Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Khuzestan, Iran.
Strongyloidiasis, a neglected tropical disease (NTD), which is caused by Strongyloides stercoralis, can be fatal in immunocompromised patients. In most chronic cases, infections most frequently are asymptomatic, and eosinophilia might be the only clinical characteristic of this disease. The use of corticosteroids in some diseases like chronic obstructive pulmonary disease (COPD) may lead to the development of the life-threatening S. Read More
Indian J Pathol Microbiol 2021 Oct-Dec;64(4):831-833
Department of Pathology, Dr. D.Y. Patil Medical College and Hospital, Sector 5, Nerul, Navi Mumbai, Maharashtra, India.
Infection with Strongyloides stercoralis, a human pathogenic roundworm, is common in tropical countries like India. Owing to its variable clinical presentation and irregular larval output in stool, it often remains neglected and underdiagnosed. Signs and symptoms are largely dependent on the immune status of the infected individual. Read More
Can Commun Dis Rep 2021 Jul 8;47(7-8):316-321. Epub 2021 Jul 8.
Ivermectin, an antiparasitic agent, is not recommended for prophylaxis or treatment of coronavirus disease 2019 (COVID-19). Inappropriate use of ivermectin for treatment of COVID-19 may make it less available for patients with serious parasitic infections who could benefit from its use and worsen the current shortage of ivermectin in Canada. However, patients with COVID-19 who are candidates to receive immunomodulatory therapies (e. Read More
Access Microbiol 2021 22;3(7):000246. Epub 2021 Jul 22.
Department of Medicine, Pushpagiri Institute of Medical Sciences and Research Centre, Tiruvalla, Kerala, India.
Introduction: is an intestinal nematode that is endemic in tropical countries. It can have a variable presentation ranging from asymptomatic eosinophilia in immunocompetent hosts to disseminated disease with sepsis in immunocompromised hosts.Case Report: We report a case of chronic diarrhoea and decreased appetite in a 53-year-old man. Read More